Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.

MLA

DiMauro, Erin F., et al. “Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure-Activity Relationships, and Inhibition of in Vivo T Cell Activation.” Journal of Medicinal Chemistry, vol. 51, no. 6, Mar. 2008, pp. 1681–94. EBSCOhost, https://doi.org/10.1021/jm7010996.

APA

DiMauro, E. F., Newcomb, J., Nunes, J. J., Bemis, J. E., Boucher, C., Chai, L., Chaffee, S. C., Deak, H. L., Epstein, L. F., Faust, T., Gallant, P., Gore, A., Gu, Y., Henkle, B., Hsieh, F., Huang, X., Kim, J. L., Lee, J. H., Martin, M. W., … Zhu, X. (2008). Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation. Journal of Medicinal Chemistry, 51(6), 1681–1694. https://doi.org/10.1021/jm7010996

Chicago

DiMauro, Erin F, John Newcomb, Joseph J Nunes, Jean E Bemis, Christina Boucher, Lilly Chai, Stuart C Chaffee, et al. 2008. “Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure-Activity Relationships, and Inhibition of in Vivo T Cell Activation.” Journal of Medicinal Chemistry 51 (6): 1681–94. doi:10.1021/jm7010996.